HOME >> MEDICINE >> NEWS
Cholesterol-lowering drugs reduce risk of stroke, heart attack

BOSTON -- People whose cholesterol improved after one month on cholesterol-lowering drugs called statins reduced their risk of stroke and heart attack, according to research that will be presented at the American Academy of Neurologys 59th Annual Meeting in Boston, April 28 May 5, 2007.

The study enrolled 4,731 people within one to six months of having a stroke or transient ischemic attack, or mini-stroke, and with no history of heart disease. Half of the participants received the cholesterol-lowering drug atorvastatin and half received a placebo. The participants were then followed for an average of four and a half years.

For each 10-percent decrease in LDL, or low-density lipoprotein bad cholesterol, the risk of stroke was reduced by four percent and the risk of heart attack was reduced by seven percent. The average decrease in LDL cholesterol after one month on atorvastatin was 53 percent.

These findings reinforce the importance of controlling cholesterol, said study author Pierre Amarenco, MD, of Denis Diderot University in Paris, France, and Fellow member of the American Academy of Neurology. Its encouraging to see that reducing cholesterol so quickly can have positive long-term effects.

People with higher levels of HDL, or high-density lipoprotein good cholesterol, at the beginning of the study and after one month had a lower risk of stroke.


'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
2-May-2007


Page: 1

Related medicine news :

1. Cholesterol-lowering drugs may be useful in an influenza pandemic
2. Cholesterol-lowering drugs not associated with increased breast cancer risk
3. UIC researchers to develop new drugs to fight bioterrorism
4. Statin drugs may delay progressive artery damage in children
5. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
6. Experts call for urgent research into anti-epileptic drugs given to children
7. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
8. Antipsychotic drugs increase risk of death in older people with dementia
9. Antipsychotic drugs increase risk of death in older people with dementia
10. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
11. Panel offers guidelines on skin reactions to new class of cancer drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... ... February 20, 2017 , ... Researchers at the University of ... well as a marker that may predict response to a particular class of drugs, ... of cancer as well. The new findings were published in Proceedings of the National ...
(Date:2/20/2017)... ... February 20, 2017 , ... Today, ... Biscom Document Router (BDR), the first IoT device from Biscom designed to deliver ... Biscom will debut BDR at HIMSS17 and will be conducting demonstrations ...
(Date:2/20/2017)... Sunapee, NH (PRWEB) , ... February 20, 2017 , ... ReportingMD, a Population Health Software ... rapid growth of the company. The new location will triple the size of the ... location for the town of Sunapee, NH. , “We are excited to expand ...
(Date:2/20/2017)... ... 2017 , ... Chuck E. Cheese’s® and Center for Autism and Related Disorders ... E. Cheese’s locations throughout New England, New York and New Jersey to provide children ... fun of visiting Chuck E. Cheese’s in a sensory-friendly environment. , After a ...
(Date:2/19/2017)... ... , ... The Citadel’s new Swain Department of Nursing , along with ... Ph.D. Joseph was engaged by the college as a consultant to help build the ... a nation-wide search, she was selected to head the department as nurse administrator, assuming ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... India , February 20, 2017 According to ... (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), ... 2021" published by MarketsandMarkets, The market is projected to reach USD 52.37 ... of 6.5% during the forecast period. Continue ... ...
(Date:2/20/2017)... 2017   Alberty   Drugs , ... has announced a significant shift in focus ... programs to servicing local Veteran Affairs Centers (VA) and ... an increased need to secure cost effective treatments for ... locally for their goods & services. "The ...
(Date:2/20/2017)... Acute, Chronic and Prophylaxis GVHD The global graft versus ... from 2016-2021 and CAGR of 3% from 2021-2027. The market is expected ... market is estimated at $0.36bn in 2016, $0.51bn in 2021, and $0.64bn ... How this report ... the future business opportunities emerging in this sector. In this ...
Breaking Medicine Technology:
Cached News: